Register of
Medicinal Products

Product class: Medicinal product with marketing authorization
Medicinal product class: Veterinary medicine
Name of medicinal product: Catophos
Active substances:
Butafosfan+Cyanocobalamin
Estonian, English, Latin
ATC code: QA12CX92
Dosage form: solution for injection
Strength: 100mg+0,05mg 1ml
Legal status for supply*: Subject to medicinal prescription
Summary of product characteristics (SPC):  (last updated December 19, 2023)
Package information leaflet (PIL): EST  (last updated December 19, 2023)
Labelling:  (last updated December 19, 2023)
Indication: As supportive treatment of metabolic or reproductive disorders, when supplementation of phosphorous and cyanocobalamin is needed. In case of peri-parturient metabolic disorders, tetany and paresis (milk fever), the product should be administered in addition to magnesium and calcium, respectively. Supporting muscle function in the presence of deficiencies of phosphorous and/or cyanocobalamin.
Safety features: No
Marketing authorization holder: CP-Pharma Handelsgesellschaft mbH 
Marketing authorization number: 1114023 
Marketing authorization issued on: May 26, 2023 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: Decentralised 
Assessment report:   
Package code Name of medicinal product Dosage form Package Legal status Reimbursements Reference price Last imported PƤritolumaa Additional information
1842779  Catophos  solution for injection  100mg +0,05mg 1ml 100ml 1TK  Prescription      18.12.2023     
1842780  Catophos  solution for injection  100mg +0,05mg 1ml 250ml 1TK  Prescription           
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere